EDUCATION & DEBATE Fortnightly Review

Total Page:16

File Type:pdf, Size:1020Kb

EDUCATION & DEBATE Fortnightly Review EDUCATION & DEBATE Fortnightly Review Fungal nail disease: a guide to good practice (report ofa Working Group ofthe British Society for Medical Mycology) D W Denning, E G V Evans, C C Kibbler, M D Richardson, M M Roberts, T R Rogers, D W Warnock, R E Warren The term onychomycosis refers to fungal infection of the nails whether this is a primary event or a secondary Summary points infection of a previously diseased or traumatised nail. Infection may be due to dermatophyte (ringworm, * Onychomycosis is usually caused by tinea unguium), yeast, or other non-dermatophyte dermatophytes (85-90%), but several fungi that (mould) species, and the clinical appearance may are difficult to treat affect toenails indicate the nature of the infecting organism. In * Paronychia is caused by many Candida paronychia chronic infection of the nail fold is most species, some resistant to azole drugs Department ofInfectious often caused by Candida species, but bacterial Diseases and Tropical infection with Gram negative species such as Pseudo- * Samples for mycology should be taken as Medicine (Monsall Unit), proximally as possible in the nail North Manchester General monas may coexist. Acute paronychia (whitlow) due to Hospital, Manchester staphylococcal infection may also occur, and the * Demonstration of hyphae in a nail specimen MS SRB presence of these bacterial infections will influence by microscopy is sufficient to start treatment D W Denning, senior lecturer management. Invasion of the nail plate by Candida * Choice of treatment depends on many factors species may occur in the presence of paronychia, including patient's age and preference, infecting PHLS Mycology Reference immune deficiency states (including chronic muco- fungus, number of nails affected, degree of nail Laboratory, Department of cutaneous candidiasis), Raynaud's disease, or involvement, whether toenails or fingernails are Microbiology, University endocrine disorders. infected, and other drugs being taken ofLeeds This paper reviews the clinical features of onycho- E G V Evans, head mycosis and the differential diagnosis ofnail dystrophy, Department ofMedical gives the reasons for appropriate mycological investi- Microbiology, Royal Free gation, and discusses guidelines for appropriate recent population survey of dermatophyte onycho- Hospital, London treatment on the basis of laboratory findings and mycosis has suggested a prevalence of 2-8% for men C C Kibbler, consultant particular clinical situations. and 2-6% for women in the United Kingdom.' Earlier surveys of swimming pools,4 schools,5 hospital Regional Mycology patients,6 and office workers7 have shown a prevalence Reference Laboratory, Epidemiology of tinea pedis of 8-40%. Of those people with tinea Department of Treating onychomycoses is difficult but is important pedis, 20-30% also have affected nails.8 This suggests of Dermatology, University because do not resolve About that the of in adults could Glasgow they spontaneously. 30% prevalence onychomycosis M D Richardson, head of all superficial fungal infections affect the nail.'2 A therefore be about 3-8%. This is difficult to assess, however, since some reports do not distinguish University Department of between dermatophytosis and other forms of onycho- Dermatology, Hope mycosis or between infection of fingernails and toe- Hospital, SalfordM6 SMD Box 1: Causes offungal nail infection nails. M M Roberts, consultant Common Uncommon Toenails are more commonly infected than finger- Dermatophytes nails.' This applies particularly to dermatophyte and Department ofInfectious Tichophyton rubrum Trichophyton erinacei mould infections, whereas Candida infections are more Diseases and Bacteriology, Trichophyton interdigitale Trchophyton soudanense Royal Postgraduate likely to affect the fingernails and fingernail folds.'" Trichophyton tonsurans Mixed infection can account for up to 5% of Medical School, London Tichophyton violaceum onycho- T R Rogers, professor Epiderinophytonfloccosum mycotic infections.'12 There is wide geographical and Microsporum canis ethnic variation in the causative species, but in Britain PHIS Mycology Reference Yeasts about 5% ofcases are due to non-dermatophyte moulds Laboratory, Public Health Candida albicans Candida glabrata * such as Scopulariopsis (see box 1) and these almost Laboratory, Bristol Candida parapsilosis Candida guillermondii exclusively affect nails. There are many cases of D W Warnock, head Candida krusei* patients who have been inappropriately treated for Candida tropicalis years because the correct diagnosis has not been Public Health Laboratory, Non-dermatophytes (moulds) established. Nail infection due to will Royal Shrewsbury Hospital Scopulariopsis Fusarium spp Aspergillus spp not respond to the standard treatments for dermato- R E Warren, director Scopulariopsis brevicaulis Acremonium spp Scytalidium dimidiatum phyte or yeast onychomycosis. Correspondence to: (Hendersonula) The increase in foreign travel has led to the intro- Dr Roberts. Scytalidium hyalinum duction of some exotic species. In addition fungi *Primanly causes ofparonychia. previously considered to be non-pathogenic may now BAM 1995;311:1277-81 be found as pathogens in patients with immune BMJ VOLUME 311 1 1 NOVEMBER 1995 1277 Clinical appearance Box 2: Typical cHnical appearance of The clinical picture of a fungal nail infection varies fungal nail dystrophy according to the nature of the infecting organism (see box 2). Involvement of adjacent skin should be noted, Dermatophyte since ifthis is due to fungal infection the treatment may Distal and lateral nail involvement spreading proximally or be different. If fungal infection is included in the Proximal subungual dystrophy or differential diagnosis then mycological examination is Superficial white dystrophy essential, even if another disease exists. Non- White or yellow thickened nails, crumbling of nail dermatophyte moulds may be present as a secondary plate invader if a nail has previously been diseased or Adjacent web or skin involvement may be present traumatised. This may account for the fact that such Candida infections often affect only one nail. Chronic paronychia Distal or lateral involvement of the nail plate Shiny red bolstered nail fold occurring at the free end of the nail and spreading Almost exclusively affects fingernail folds proximally is particularly associated with Trichophyton Loss ofcuticle rubrum infection or some non-dermatophyte infections. Pus exuding from under nail fold Eventually the whole nail may be affected, and there Usually proximal nail involvement may be proximal subungual nail dystrophy with Distal nail dystrophy-associated with circulatory separation of the nail from the bed. In superficial disorders white onychomycosis, crumbly white areas are evident Total dystrophic onychomycosis-chronic muco- cutaneous candidosis on the nail surface particularly in patients with Nails white, green, or occasionally black AIDS. T interdigitale causes this type of appearance. Paronychia is seldom present in a dermatophyte Non-dermatophyte infection, but Candida infection often begins in the Superficial white onychomycosis proximal nail plate and paronychia is common. In Often solitary nail involvement-more often toenail chronic mucocutaneous candidosis, a rare T cell dis- Colour ofnail may be influenced by nature of infecting mould. For example: order with disabling mucosal candidiasis, total nail Acremonium spp-superficial white onychomycosis dystrophy is usual. Scopulariopsis spp-white, yellow, brown, or green Scytalidium spp-white or black Fusatium spp-white Differential diagnosis Alternaria spp-brown Several conditions may be associated with nail Aspergillus spp-green or black dystrophy, including bacterial and fungal infection (see box 3). Sometimes bacterial infection may coexist with fungal infection and may require treatment in its deficiency and are often associated with a high own right. Many other conditions can cause a change in mortality. For example, Fusarium species may cause the appearance ofthe nail, but the nail surface does not onychomycosis, usually with a solitary toenail usually become soft and friable as in a fungal infection. infection and sometimes with paronychia. This If there is any doubt a specimen should be taken for may provide a portal of entry leading to dissemi- mycological examination. nated infection in immunocompromised patients, In some cases of psoriasis and eczema there may be particularly those with haematological conditions fungal superinfection of the nails. Yeasts and bacteria and AIDS. are often found in subungual debris from psoriatic Box 3: Non-fimgal conditions particularly associated with nail dystrophy Bacterial nail infection Lichen planus Pseudomonas aeruginosa-green or black dis colour- Pterygium formation from cuticle ation Longitudinal ridging ofnails Staphylococcus aureus may present as acute paronychia Total nail loss, usually permanent (whitlow) May be lichen planus elsewhere Onychogryphosis Alopecia areata and alopecia totalis Grossly thickened and distorted horn-like appearance Solitary or multiple nail dystrophy ofnail Variable severity ofnail dystrophy Overcurvature ofnail Diffuse fine pitting, often in transverse lines Great toenails most commonly affected Frequent onychorhexis (fragmented nails) and ridging May follow trauma Onset ofnail dystrophy may not coincide with hair loss Psoriasis Yellow nail syndrome Yellow friable nails with pitting and onycholysis Slow growing nails (lifting ofnail from bed) Smooth overcurved
Recommended publications
  • Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Therapeutic Class Overview Antifungals, Topical
    Therapeutic Class Overview Antifungals, Topical INTRODUCTION The topical antifungals are available in multiple dosage forms and are indicated for a number of fungal infections and related conditions. In general, these agents are Food and Drug Administration (FDA)-approved for the treatment of cutaneous candidiasis, onychomycosis, seborrheic dermatitis, tinea corporis, tinea cruris, tinea pedis, and tinea versicolor (Clinical Pharmacology 2018). The antifungals may be further classified into the following categories based upon their chemical structures: allylamines (naftifine, terbinafine [only available over the counter (OTC)]), azoles (clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, oxiconazole, sertaconazole, sulconazole), benzylamines (butenafine), hydroxypyridones (ciclopirox), oxaborole (tavaborole), polyenes (nystatin), thiocarbamates (tolnaftate [no FDA-approved formulations]), and miscellaneous (undecylenic acid [no FDA-approved formulations]) (Micromedex 2018). The topical antifungals are available as single entity and/or combination products. Two combination products, nystatin/triamcinolone and Lotrisone (clotrimazole/betamethasone), contain an antifungal and a corticosteroid preparation. The corticosteroid helps to decrease inflammation and indirectly hasten healing time. The other combination product, Vusion (miconazole/zinc oxide/white petrolatum), contains an antifungal and zinc oxide. Zinc oxide acts as a skin protectant and mild astringent with weak antiseptic properties and helps to
    [Show full text]
  • Below Chart Lists Over-The-Counter (OTC) Medicines Considered Low Risk for Pregnant Women When Taken for the Occasional Mild Illness
    Below chart lists over-the-counter (OTC) medicines considered low risk for pregnant women when taken for the occasional mild illness. It also mentions a few that are not safe. A few brand names are listed as examples, but there are many more on the market. Of course, nothing is 100 percent safe for all women, so it's a good idea to check with your doctor before taking any kind of medicine during pregnancy – even an over-the-counter product. Don't take more than the recommended dose and, if possible, avoid taking anything during your first trimester, when your developing baby is most vulnerable. NOTE: If you have a question about the safety of any medication during pregnancy, visit the Organization of Teratology Information Specialists Web site. There you'll find fact sheets on various drugs and exposures that can affect your baby as well as a list of teratogen information services that you can contact. Problem Safe to take Heartburn, gas and Antacids for heartburn (Maalox, Mylanta, Rolaids, Tums) bloating, upset stomach Simethicone for gas pains (Gas-X, Maalox Anti-Gas, Mylanta Gas, Mylicon) Cough or cold Guaifenesin, an expectorant (Hytuss, Mucinex, Naldecon Senior EX, Robitussin) Dextromethorphan, a cough suppressant (Benylin Adult, Robitussin Maximum Strength Cough, Scot-Tussin DM, Vicks 44 Cough Relief) Guaifenesin plus dextromethorphan (Benylin Expectorant, Robitussin DM, Vicks 44E) Cough drops Vicks VapoRub Not safe to take: Cold remedies that contain alcohol The decongestants pseudoephedrine and phenylephrine, which can affect blood
    [Show full text]
  • Ascosphaerales)
    INIII;ITION OFC1[ALKBROOD SPORE GERMINATIONIN VITRO (Ascosp haera aggrega ta: Ascosphaerales) Station Bulletin 656 January 1982 Agricultural Fxperiment Station Oreg' State University, Corvallis ¶ INHIBITION OF CHALKBROOD SPORE GERMINATION IN VITRO (Ascosphaera aggregata: Ascosphaerales.) W. P. Stephen, J.D. Vandenberg, B. L. Fichter, and G. Lahm Authors: Professor, research assistants and technician in theDepartment of Entomology, Oregon State University. ABSTRACT Sixty-five compounds, including general microbicides, fungicides, antibiotics, and fumigants were screened for their sporicidal effect on Ascosphaera aggregata. The chalkbrood spore, the only readily accessible stage of the fungus, was unaffected by most of the materials tested. Only the halogenated general microbicides, iodine, hypochiorite, and stabilized dry chlorine, demonstrated consistent sporicidal activity at low concen- trations. Suggestions are made as to possible disease control strategies. ACKNOWLEDGMENTS The Multistate Chalkbrood Project is supported by contributions from grower groups and industry representatives in Idaho, Nevada, Oregon, and Washington; the Idaho, Nevada, and Washington Alfalfa Seed Commissions; Universities of Idaho and Nevada-Reno; Oregon and Washington State Universities, and by a cooperative agreement with the USDA/SEA Federal Bee Laboratory, Logan, Utah. The authors thank Dr. J. Corner and Mr. D. McCutcheon, British Columbia Ministry of Agriculture and Food, Vernon and Surrey, B.C., for help with the ETO tests; Dr. G. Puritch, Canadian Forestry Service, Pacific Forest Research Center, Victoria, B.C., for supplying the fatty acid derivatives; and Dr. D. Coyier, IJSDA/SEA/AR Ornamental Plants Laboratory, Corvallis, Ore., for assistance with fumigation studies. 1 INTRODUCTION Ascosphaera aggregata Skou is the causative agent ofchalkbrood in larvae of the alfalfa leafcutting bee, Megachilerotundata (Fabricius) (Vandenberg and Stephen, 1982).
    [Show full text]
  • Antifungal Drugs
    Antifungal Drugs Antifungal or antimycotic drugs are those agents used to treat diseases caused by fungus. Fungicides are drugs which destroy fungus and fungistatic drugs are those which prevent growth and multiplication of fungi. Collectively these drugs are often referred to as antimycotic or antifungal drugs. General characteristics of fungus: Fungi of medical significance are of two groups: Yeast Unicellular (Candida, Crytococcus) Molds Multicellular; filamentous consist of hyphae (Aspergillus, Microsporum, Trichophyton) They are eukaryotic i.e. they have well defined nucleus and other nuclear materials. They are made of thin threads called hyphae. The hyphae have a cell wall (like plant cells) made of a material called chitin. The hyphae are often multinucleate. They do not have chlorophyll, can’t make own food by photosynthesis, therefore derive nutrients by means of saprophytic or parasitic existence. Cell membrane is made up of ergosterol. Types of fungal infections: Fungal infections are termed as mycoses and in general can be divided into: Superficial infections: Affecting skin, nails, scalp or mucous membranes; e.g. Tinea versicolor Dermatophytosis: Fungi that affect keratin layer of skin, hair and nail; e.g. Tinea pedis, rign worm infection. Candidiasis: Yeast infections caused by (Malassezia pachydermatis), oral thrush (oral candidiasis), vulvo-vaginitis, nail infection. Systemic/Deep infections: Affecting deeper tissues and organ they usually affect lungs, heart and brain leading to pneumonia, endocarditis and meningitis. Systemic infections are associated with immunocompromised patients, these diseases are serious and often life threatening due to the organ involved. Some of the serious systemic fungal infections in man are candidiasis, cryptococcal meningitis, pulmonary aspergillosis.
    [Show full text]
  • Nails: Tales, Fails and What Prevails in Treating Onychomycosis
    J. Hibler, D.O. OhioHealth - O’Bleness Memorial Hospital, Athens, Ohio AOCD Annual Conference Orlando, Florida 10.18.15 A) Onychodystrophy B) Onychogryphosis C)“Question Onychomycosis dogma” – Michael Conroy, MD D) All the above E) None of the above Nail development begins at 8-10 weeks EGA Complete by 5th month Keratinization ~11 weeks No granular layer Nail plate growth: Fingernails 3 mm/month, toenails 1 mm/month Faster in summer or winter? Summer! Index finger or 5th digit nail grows faster? Index finger! Faster growth to middle or lateral edge of each nail? Lateral! Elkonyxis Mee’s lines Aka leukonychia striata Arsenic poisoning Trauma Medications Illness Psoriasis flare Muerhrcke’s bands Hypoalbuminemia Chemotherapy Half & half nails Aka Lindsay’s nails Chronic renal disease Terry’s nails Liver failure, Cirrhosis Malnutrition Diabetes Cardiovascular disease True or False: Onychomycosis = Tinea Unguium? FALSE. Onychomycosis: A fungal disease of the nails (all causes) Dermatophytes, yeasts, molds Tinea unguium: A fungal disease of nail caused by dermatophyte fungi Onychodystrophy ≠ onychomycosis Accounts for up to 50% of all nail disorders Prevalence; 14-28% of > 60 year-olds Variety of subtypes; know them! Sequelae What is the most common cause of onychomycosis? A) Epidermophyton floccosum B) Microsporum spp C) Trichophyton mentagrophytes D) Trichophyton rubrum -Account for ~90% of infections Dermatophytes Trichophyton rubrum Trichophyton mentagrophytes Trichophyton tonsurans, Microsporum canis, Epidermophyton floccosum Nondermatophyte molds Acremonium spp, Fusarium spp Scopulariopsis spp, Sytalidium spp, Aspergillus spp Yeast Candida parapsilosis Candida albicans Candida spp Distal/lateral subungal Proximal subungual onychomycosis onychomycosis (DLSO) (PSO) Most common; T. rubrum Often in immunosuppressed patients T.
    [Show full text]
  • Preserving the Faith a Cosmetic Formulators Overview John Woodruff John Woodruff: the Personal Stuff
    Preserving the faith A cosmetic formulators overview John Woodruff www.creative-developments.co.uk John Woodruff: the personal stuff 1960: joined Smith & Nephew Research 1976: Co-founded Pava, responsible for all technical aspects, from formulation and development to manufacture and filling and originated many well-known brands. October 1988: Established consulting laboratory for formulation of cosmetics and toiletry products. Developed Creativity a unique programme written for formula creation and cosmetic manufacture Two books and many articles published on cosmetic technology. Twice appeared as an expert witness, 3 times Chairman of the European UV & Sun Filters Conference, Twice chaired a technical session at In-Cosmetics 1990 – 1996: Cosmetics Consultant to Manufacturing Chemist 1996 – Present: Regular contributions to Soap, Perfumery and Cosmetics (SPC) Supports the Distance Leaning Course run by the SCS Lectures on product formulation at the Principles and Practice of Cosmetic Science When he is not working he is sailing. 2 The cosmetic product brief • Product type • Claims • Product format • Application • Texture • Colour • Perfume • Packaging • Cost 3 What about the preservative? Preservatives are one of the last things that most chemists think about when formulating a product and one of the first things that are suspected when a problem occurs. They are important ingredients, the value of which is never noticed when functioning properly and which are worthless when not. Preservatives are much maligned and misunderstood within the cosmetics industry. Because of this, they are often over-dosed, under-dosed or improperly formulated even by experienced chemists Cosmetic formulations require a delicate balance of a large number of raw materials.
    [Show full text]
  • A Full Portfolio of Office-Dispensed Therapeutic Products for the Podiatry Practice
    PRODUCT CATALOG A Full Portfolio of Office-dispensed Therapeutic Products for the Podiatry Practice 1 NEW PRODUCT Patients Can Now Condition Their Nails While Wearing Their Own Nail Polish! A Full Portfolio of Office-dispensed Therapeutic Products for the Podiatry Practice To complement our pathology services, Bako Diagnostics offers a complete line of office- dispensed, therapeutic solutions for the management of conditions related to skin and CLARUS™ Nail Polish ENHANCER nail units. By integrating therapeutic suggestions 1 fl. oz. (30 mL) with our services we are able to empower you to INGREDIENTS improve the health of your podiatric patients. Undecylenic Acid, Biotin, Antioxidants, Tea Tree Oil, Thymol USE Conditions nails while wearing nail polish To order products ATTRIBUTES Simple to use: 1 dropperful (mL) conditions one bottle call 855-422-5628 of personal nail polish Economical: one bottle conditions 30 bottles of nail polish Paraben-free 1 CLARUS™ CLARUS™ CLARUS™ CLARUS™ Antifungal Solution Antifungal Cream Antimicrobial Shoe Spray Fungal Eradication Kit 0.5 oz 3.0 oz pump 6.0 fl oz INGREDIENTS INGREDIENTS INGREDIENTS KIT CONTAINS Tolnaftate 1% in a penetrating vehicle 1% Tolnaftate in a vehicle containing 20% Nanosilver with added Tolnaftate CLARUS Antifungal Solution containing Mentha Piperita Oil, Essential Urea and Tea Tree Oil CLARUS Antifungal Cream Fatty Acids, and Antioxidant USE CLARUS Antimicrobial Shoe Spray USE Antibacterial USE Tinea Pedis (Athlete’s foot) USE Antifungal action AntifungaI Tinea Corporis (Ringworm)
    [Show full text]
  • Leucidal® Liquid PT
    Leucidal® Liquid PT Technical Data Sheet BACKGROUND Consumer choice is the most important factor when it comes to cosmetic Code Number: M15021 sales. Today, a growing number of consumers are opting to move INCI Nomenclature: away from synthetic preservatives such as parabens, formaldehyde Lactobacillus Ferment donors and phenoxyethanol. In addition to public pressure, the use of INCI Status: Conforms these synthetic materials in cosmetics is also becoming more strictly REACH Status: Fully Compliant regulated. For these reasons, formulators have been actively searching CAS Number: 68333-16-4 for alternatives to synthetic preservatives that can provide broad EINECS Number: N/A spectrum antimicrobial activity. Origin: Biotechnology Lactobacillus Active Micro Technologies (AMT) has developed a full line of Processing: products derived from naturally occurring compounds that provide GMO Free broad spectrum antimicrobial protection. As a result, these novel No Ethoxylation natural antimicrobials can be used as consumer-friendly alternatives No Irradiation No Sulphonation to synthetic preservatives in a wide range of cosmetic applications. No Ethylene Oxide treatment No Hydrogenation Leucidal Liquid PT is a versatile natural antimicrobial, suitable for Additives: None both emulsions and anhydrous applications such as pressed powders. -Preservatives: None Pressed powders typically require water- -Antioxidants: None free preservatives capable of providing Other additives: None broad antimicrobial protection. One of Solvents used: Water the most commonly used preservatives Appearance: in pressed powders is ethylparaben. Clear to Slightly Hazy Liquid Even though it is an effective product, Soluble/Miscible: this synthetic preservative is one of the Water Soluble materials that is becoming more strictly Suggested Use Levels: 2.0% regulated, while simultaneously losing Suggested Applications: consumer preference.
    [Show full text]
  • Undecylenic Acid Cream Blaine Labs Inc. Disclaimer: Most
    TINEACIDE PHYSICIAN FORMULA - undecylenic acid cream TINEACIDE - undecylenic acid cream Blaine Labs Inc. Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- Active Ingredients Undecylenic Acid Inactive Ingredients Aloe Vera, Cetyl Alcohol, Clotrimazole, Coco-Caprylate Caprate, Disodium EDTA, Glyceryl Stearate, Hydroxyethylcellulose, Lavender Oil, Methylparaben, PEG-100, Stearate, Polysorbate 60, Propylparaben, Stearic Acid, Tea Tree Oil, Triethanolamine, Urea, Water Uses Cures Athlete's Foot (tinea pedis) jock itch (tinea cruris) and ringworm (tinea corporis). Uses For effective relief of itching, cracking, burning and discomfort which can accompany these conditions. Ask Your Physician Do not use on children under 2 years of age unless directed by a physician When Using This Product Wash the affected area with soap and water and dry thoroughly. Apply sparingly over affected area twice daily (morning and night) or as directed by a physician. For athlete's foot pay special attention to spaces between the toes. wear well-fitting ventilated shoes and change shoes and socks at least once daily. For athlete's foot and ringworm use daily for 4 weeks. for jock itch use daily for 2 weeks. If condition persists longer, consult a physician. Warnings For external use only. Avoid contact with eyes. If irritation occurs or if there is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch) discontinue use and consult a physician. Keep this and all drugs out of the reach of children.
    [Show full text]
  • Antifungal Agents
    Antifungal agents Mohammed Nooraldeen Al-Qattan (PhD) Introduction • The development of chemotherapy to treat fungal infections is much lagged behind those to treat bacterial infections. This is because fungal infections are: - Usually superficial to skin and mucosal membranes - Rarely lethal - Easily coped by human immune system • The antifungal agents is mostly required in immunocompromised patients such as those receiving cancer chemotherapy, immunosuppressant after organ transplant and HIV patients. Introduction • Fungal kingdom includes yeasts, molds, rusts and mushrooms. • Fungi could be 1. Saprophytes, live on dead organic matter. 2. Obligate animal parasite, live only on mammalian hosts such as Candida albicans (normal flora of GIT and vagina). 3. Dermatophytes, - Live on/in keratin-containing hair, skin and nails of mammals. - It attacks the cross-linked structural protein keratin. - Called tinea and can infect hair and scalp (tinea capitis), feet (tinea pedis), hand (tinea manuum), nails (tinea ungunium) Biochemical targets for antifungal agents • Antifungal chemotherapy depends on biochemical differences between fungi and mammal cells. Such differences are few since both type of cells are eukaryotics. Example of such differences 1. Fungal cells have both cell membrane and outer cell wall, whereas mammalian cells only have cell membrane 2. The membranes of fungal and mammalian cells have different types of sterols (i.e. Ergosterol and cholesterol, respectively). Brown, Lisa, et al. "Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi." Nature Reviews Microbiology 13.10 (2015): 620-630. Biochemical targets for antifungal agents (Cont.) C D A B • Although the ergosterol and cholesterol are quite similar, the side chains are slightly different, and when three-dimensional models are constructed, the ring system of ergosterol is slightly flatter because of the additional double bonds in the B ring.
    [Show full text]
  • Salts of Undecylenic Acid ( Undecylenates )
    www.CastorOilDerivatives.com www.AkshayChemicals.in SALTS OF UNDECYLENIC ACID ( UNDECYLENATES ) The undecylenic acid (10-undecenoic acid), an eleven-carbon monounsaturated fatty acid is a naturally occurring fatty acid found in the castor oil bean (Ricinus communis) and as a product of human sweat glands. It is produced commercially through the vacuum distillation of castor bean oil and pyrolysis of ricinoleic acid . Since 1949, the undecylenate salts have been used as yeast and mold inhibitors in the food industry, and in medicine as topical and systemic antifungals .Following are the useful salts of Undecylenic acid. POTASSIUM UNDECYLENATE (Potassium Salt of Undecylenic Acid) Potassium salts of fatty acids are commonly called soap salts. They are used as insecticides, herbicides, fungicides, and algaecides. Some potassium salts of fatty acids are used as multi-purpose food additives. The Food and Drug Administration (FDA) classifies them as GRAS (generally recognized as safe) .Potassium salts of fatty acids have been exempt from United States Environmental Protection Agency (EPA) tolerances for food and feed crops since 1982. Potassium salt formation provides water solubility for the fatty acids. These salts are also called as insecticidal soap.It has also been approved in the United States for use against powdery mildew. In the European pesticide registration, its use as an insecticide is listed for aphids, white fly, and spider mites.At different concentrations, it may also be used against algae and moss. Potassium salts of fatty acids can also be fungicidal. As with its insecticidal activity, fungicidal effects increase with additional carbon chain lengths. Greatest toxic effects occur at C10 or C11 then decrease.
    [Show full text]